Rapid Discovery of Aβ42 Fibril Disintegrators from Ganoderma lucidum via Ligand Fishing and Their Neuroprotective Effects on Alzheimer's Disease

An amyloid-β (Aβ) fibril is a vital pathogenic factor of Alzheimer's disease (AD). Aβ fibril disintegrators possess great potential to be developed into novel anti-AD agents. Here, a ligand fishing method was employed to rapidly discover Aβ42 fibril disintegrators from Ganoderma lucidum using Aβ42 fibril-immobilized magnetic beads, which led to the isolation of six Aβ42 fibril disintegrators including ganodermanontriol, ganoderic acid DM, ganoderiol F, ganoderol B, ganodermenonol, and ergosterol. Neuroprotective evaluation in vitro exhibited that these Aβ42 fibril disintegrators could significantly mitigate Aβ42-induced neurotoxicity. Among these six disintegrators, ergosterol and ganoderic acid DM with stronger protecting activity were further selected to evaluate their neuroprotective effect on AD in vivo. Results showed that ergosterol and ganoderic acid DM could significantly alleviate Aβ42-induced cognitive dysfunction and hippocampus neuron loss in vivo. Moreover, ergosterol and ganoderic acid DM could significantly inhibit Aβ42-induced neuron apoptosis and Nrf2-mediated neuron oxidative stress in vitro and in vivo.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:72

Enthalten in:

Journal of agricultural and food chemistry - 72(2024), 8 vom: 28. Feb., Seite 4127-4141

Sprache:

Englisch

Beteiligte Personen:

Li, Qiang-Ming [VerfasserIn]
Han, Hui-Hui [VerfasserIn]
Zang, Dan-Dan [VerfasserIn]
Zha, Xue-Qiang [VerfasserIn]
Zhou, An [VerfasserIn]
Zhang, Feng-Yun [VerfasserIn]
Luo, Jian-Ping [VerfasserIn]

Links:

Volltext

Themen:

3,7-dioxolanosta-8,24-dien-26-oic acid
Aβ fibril disintegrator
Alzheimer’s disease
Amyloid
Amyloid beta-Peptides
Ergosterol
Ganoderma lucidum
Journal Article
Ligand fishing
Ligands
Magnetic beads
Neuroprotective Agents
Peptide Fragments
Triterpenes
Z30RAY509F

Anmerkungen:

Date Completed 29.02.2024

Date Revised 29.02.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1021/acs.jafc.3c08664

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM368529541